Recipharm further extends the acceptance period for the offer to acquire Consort Medical and updates on level of acceptance
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION. THIS PUBLICATION IS NEITHER AN OFFER TO BUY OR SELL NOR AN INVITATION TO TENDER OR OFFER TO BUY OR SELL SHARES. Read the whole press release here . For more information please visit www.recipharm.com or contact:Tobias Hägglöv, CFO This information is information that Recipharm AB (publ) is obliged to make public pursuant to the EU Market